← Back to Search

Filter Ventilation for Tobacco Use

N/A
Waitlist Available
Led By Dorothy K Hatsukami, Ph.D
Research Sponsored by Masonic Cancer Center, University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 21 years of age
Be older than 18 years old
Must not have
Unstable medications
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days prior to baseline visit and 7 days prior to week 6 visit
Awards & highlights

Summary

This trial will test the effects of different degrees of cigarette filter ventilation on biomarkers of exposure to toxins and on smoking behavior. Additionally, the study will explore how these changes impact a smoker's dependence on cigarettes and their subjective responses to smoking.

Who is the study for?
This trial is for regular cigarette smokers who are at least 21 years old and have their smoking status confirmed biochemically. It's not suitable for individuals with unstable health conditions, those on fluctuating medications, or pregnant or nursing women.Check my eligibility
What is being tested?
The study is testing the effects of cigarettes with ventilated filters versus unventilated filters on toxicant exposure and smoking behavior. Participants will be monitored for changes in urinary biomarkers and their responses to the cigarettes.See study design
What are the potential side effects?
While specific side effects are not detailed, potential risks may include changes in smoking behavior due to different filter types which could affect toxin intake.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 21 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My medications have been stable for the last month.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days prior to baseline visit and 7 days prior to week 6 visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days prior to baseline visit and 7 days prior to week 6 visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Total NNAL: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol
Change in cigarettes per day (CPD)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Ventilated Cigarette FilterExperimental Treatment1 Intervention
Filters with approximately 24-32% filter ventilation
Group II: Unventilated Cigarette FilterExperimental Treatment1 Intervention
Filters with approximately 0-5.0% filter ventilation

Find a Location

Who is running the clinical trial?

Masonic Cancer Center, University of MinnesotaLead Sponsor
276 Previous Clinical Trials
14,647 Total Patients Enrolled
6 Trials studying Tobacco Use
254 Patients Enrolled for Tobacco Use
Ohio State UniversityOTHER
844 Previous Clinical Trials
639,293 Total Patients Enrolled
2 Trials studying Tobacco Use
118 Patients Enrolled for Tobacco Use
Dorothy K Hatsukami, Ph.DPrincipal InvestigatorMasonic Cancer Center, University of Minnesota
2 Previous Clinical Trials
168 Total Patients Enrolled
1 Trials studying Tobacco Use
118 Patients Enrolled for Tobacco Use

Media Library

Unventilated Cigarette Filter Clinical Trial Eligibility Overview. Trial Name: NCT04969783 — N/A
Tobacco Use Research Study Groups: Ventilated Cigarette Filter, Unventilated Cigarette Filter
Tobacco Use Clinical Trial 2023: Unventilated Cigarette Filter Highlights & Side Effects. Trial Name: NCT04969783 — N/A
Unventilated Cigarette Filter 2023 Treatment Timeline for Medical Study. Trial Name: NCT04969783 — N/A
~53 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top